Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients previously treated

Journal of Urology

Volumn 166, Issue 2, 2001, Pages 494-499

  Talcott, James A ^a   Clark, Jack A ^a   Stark, Paul C ^a   Mitchell, Sonya P ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Brachytherapy; Impotence; Prostatic neoplasms; Quality of life; Urinary incontinence

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; ERECTILE DYSFUNCTION; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IMPOTENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; TRANSURETHRAL RESECTION; URINE INCONTINENCE;

EID: 0034947339     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65970-8     Document Type: Article

References (41)

1. Patient-reported complications and followup treatment after radical prostatectomy: The National Medicare Experience: 1988-1990 (updated June 1993)
2. Quality-of-life outcomes in men treated for localized prostate cancer
3. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study
4. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy
5. Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study
6. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study
7. The role of increasing detection in the rising incidence of prostate cancer
8. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
9. Retropubic implantation to iodine 125 in the treatment of prostatic cancer
10. Irradiation treatment of carcinoma of the prostate: A preliminary report based on 8 years of experience
11. I-125 interstitial implantation for prostate cancer: What have we learned 10 years later?
12. 125iodine implantation to control localized prostate cancer: A study of 41 patients
13. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: The jury is still out
14. Prostate cancer: The therapeutic challenge of locally advanced disease
15. Brachytherapy and organ preservation in the management of carcinoma of the prostate
16. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma
17. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma
18. Transperineal palladium 103 prostate brachytherapy: Analysis of morbidity and seed migration
19. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma
20. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer
21. Prostate specific antigen-monitored combination radiotherapy for patients withprostate cancer - I-125 implant followed by external-beam radiation
22. Long-term complications of treatment for early prostate cancer: 2-Year followup in a prospective, multi-institutional outcomes study
23. Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas
24. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma
25. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma
26. Complications of treatment for early prostate cancer: A prospective, multi-institutional outcomes validation study
27. Brachytherapy (seed implantation) for clinically localized prostate cancer
28. Interstitial implantation techniques in prostate cancer
29. Transperineal ultrasound-guided implantation of the prostate: Morbidity and complications
30. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study
31. Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy
32. Prostate cancer: Post-irradiation incontinence
33. Transurethral resection of the prostate among Medicare beneficiaries in the United States: Time trends and outcomes -Prostate Patient Outcomes Research Team (PORT)
34. Prostate conditions, treatment decisions, and patient preferences
35. Effect of radical prostatectomy for prostate cancer on patient quality of life: Results from a Medicare survey
36. A dose-response study for I-125 prostate implants
37. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy
38. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43
39. Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I: American Association of Physicists in Medicine
40. Defining the implant treatment volume for patients with low risk prostate cancer: Does the anterior base need to be treated?
41. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer